<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hočevar, Sandra</dc:creator>
  <dc:creator>Milosevic, Ana</dc:creator>
  <dc:creator>Rodriguez-Lorenzo, Laura</dc:creator>
  <dc:creator>Ackermann-Hirschi, Liliane</dc:creator>
  <dc:creator>Mottas, Inès</dc:creator>
  <dc:creator>Petri-Fink, Alke</dc:creator>
  <dc:creator>Rothen-Rutishauser, Barbara</dc:creator>
  <dc:creator>Bourquin, Carole</dc:creator>
  <dc:creator>Clift, Martin J. D.</dc:creator>
  <dc:date>2019-06-25</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Gold nanoparticles (GNPs) are intended for use within a variety of biomedical  applications due to their physicochemical properties. Although, in general,  biocompatibility of GNPs with immune cells such as macrophages and dendritic cells  is well established, the impact of GNPs on B lymphocyte immune function remains to  be determined. Since B lymphocytes play an important role in health and disease, the  suitability of GNPs as a B cell-targeting tool is of high relevance. Thus, we provide  information on the interactions of GNPs with B lymphocytes. Herein, we exposed  freshly isolated human B lymphocytes to a set of well-characterized and biomedically  relevant GNPs with distinct surface (polyethylene glycol (PEG), PEG/poly(vinyl  alcohol) (PEG/PVA)) and shape (spheres, rods) characteristics. Polymer-coated  GNPs poorly interacted with B lymphocytes, in contrast to uncoated GNPs.  Importantly, none of the GNPs significantly affected cell viability, even at the highest  concentration of 20 μg/mL over a 24 h suspension exposure period. Furthermore,  none of the nanosphere formulations affected the expression of activation markers  (CD69, CD86, MHC II) of the naive B lymphocytes, nor did they cause an increase in  the secretion of pro-inflammatory cytokines (i.e. , IL-6, IL-1β). However, the absence  of polymer coating on the sphere GNPs and the rod shape caused a decrease in IL-6  cytokine production by activated B lymphocytes, suggesting a functional impairment.  With these findings, the present study contributes imperative knowledge toward the  safe-by-design approaches being conducted to benefit the development of  nanomaterials, specifically those as theranostic tools.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308104</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308104/files/pet_pcg.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308104/files/pet_pcp_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1021/acsnano.9b01492</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>ACS Nano. - 2019, vol. 13, no. 6, p. 6790–6800</dc:source>
  <dc:subject>info:eu-repo/classification/udc/54</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Polymer-coated gold nanospheres do not impair the innate immune function of human b lymphocytes in vitro</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
